Andrew Huberman· PhD
And, in fact, Bill Harris, Dr. Bill Harris, he's just one of the pioneers on omega-3 fatty acid research. He was on our podcast last August. And he was saying the reason FDA chose that was literally just because how much they could get people to take. It wasn't like an upper end, like anything above that is unsafe. That wasn't the case. I mean, it was just purely cost and compliance, so what they can